Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 439-444

  Van Der Poll, Tom ^b   Keogh, Christopher V ^b   Guirao, Xavier ^b   Buurman, Wim A ^b   Kopf, Manfred ^b   Lowry, Stephen F ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; HOST RESISTANCE; IMMUNE RESPONSE; LOBAR PNEUMONIA; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0030856428     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514062     Document Type: Article

References (13)

1. Garibaldi RA. Epidemiology of community-acquired respiratory tract infection in adults: incidence, etiology, and impact. Am J Med 1985;78: S32-7.
2. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
3. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: a 5 year prospective study. Rev Infect Dis 1989;11:586-99.
4. Torres A, Serra-Batlles J, Ferrer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991;144:312-8.
5. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae, N Engl J Med 1994;331:377-82.
6. Hack CE, de Groot ER, Felt-Bersma RJF, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-10.
7. Dehoux MS, Boutten A, Ostinelli J, et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994;150:710-6.
8. Puren AJ, Feldman C, Savage N, Becker PJ, Smith C. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995;107:1342-9.
9. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-42.
10. Van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin 10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996;174:994-1000.
11. Van der Poll T, Keogh CV, Buurman WA, Lowry SF. Passive immunization against tumor necrosis factor α impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 1997;155:603-8.
12. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-109.
13. Bemelmans MHA, Gouma DJ, Buurman WA. Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 1994;6:608-15.